Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SkinCeuticals CE + RBE is a topical antioxidant regimen consisting of two synergistic products: C E Ferulic (daytime) and Resveratrol B E (nighttime). Developed by SkinCeuticals (a L'Oréal brand), this combination was specifically evaluated in clinical research conducted by the Shanghai Dermatology Hospital for its efficacy in treating photo-aging. C E Ferulic is a daytime serum containing 15% L-ascorbic acid, 1% alpha-tocopherol, and 0.5% ferulic acid, which provides advanced environmental protection by neutralizing free radicals induced by UVA/UVB and infrared radiation. Resveratrol B E is a nighttime concentrate featuring 1% pure resveratrol, 0.5% baicalin, and 1% alpha-tocopherol, designed to boost the skin's internal antioxidant defense system and support natural repair processes. Together, the regimen is used to improve the appearance of fine lines, wrinkles, and skin firmness while enhancing overall radiance and correcting signs of photo-damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbic acid + alpha-tocopherol + ferulic acid + resveratrol + baicalin.